(Q34011549)

30 July 2017

title

The strong financial case for regenerative medicine and the regen industry (English)

1 reference

30 July 2017

main subject

regenerative medicine

1 reference

Chris Mason

1

1 reference

30 July 2017

Peter Dunnill

series ordinal

2

1 reference

30 July 2017

publication date

1 May 2008

1 reference

30 July 2017

published in

Regenerative Medicine

1 reference

30 July 2017

volume

3

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

351-363

1 reference

A brief definition of regenerative medicine

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Practical issues in stem cell therapy for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Alzheimer's disease and neural transplantation as prospective cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Neural stem cells improve memory in an inducible mouse model of neuronal loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Stem cell approaches for the treatment of renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Burden of illness in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Autologous olfactory ensheathing cell transplantation in human spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Adult mesenchymal stem cells and impaction grafting: a new clinical paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

A clinical development paradigm for cancer vaccines and related biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Cancer stem cells: models and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Embryonic stem cells and retinal repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

The burden and costs of chronic diseases in low-income and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Regenerative medicine and the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Proposition 71 and CIRM--assessing the return on investment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Cost-utility analysis of pacemakers for the treatment of vasovagal syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Tissue-engineered autologous bladders for patients needing cystoplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Genzyme: 15 years of cell and gene therapy research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Regenerative medicine bioprocessing: building a conceptual framework based on early studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

History of regenerative medicine: looking backwards to move forwards

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

The costs of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Heart transplantation in the Netherlands; costs, effects and scenarios

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Kidney transplantation in the elderly: a decision analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460751.3.3.351

21 January 2018

Identifiers

DOI

10.2217/17460751.3.3.351

1 reference

30 July 2017

1 reference